Company / Profit Margin
CHINA PHARMA HOLDINGS, INC. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-76.9%
FY2025
5-year range
-76.9% / -26.4%
FY2021-FY2025
Trend
-75.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -189.5% in FY2020 to -26.4% in FY2021.
Based on SEC 10-K filings.
-76.9% in FY2025 with a 5-year CAGR of +112.6%.
Declined from -43.9% to -76.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -27.9pp
- 5-Year Change
- +112.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 75.2% year-over-year.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -76.9% | -75.2% |
| FY2024 | -43.9% | +0.0% |
| FY2023 | -43.9% | +10.4% |
| FY2022 | -49.0% | -85.8% |
| FY2021 | -26.4% | +86.1% |
| FY2020 | -189.5% | -117.4% |
| FY2019 | -87.2% | +40.3% |
| FY2018 | -145.9% | -147.4% |
| FY2017 | -59.0% | +22.1% |
| FY2016 | -75.7% | +57.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026